nitazoxanide has been researched along with Hepatic Encephalopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Elsalam, SM; Glal, KAM; Mostafa, TM | 1 |
| Abd-Elsalam, S; Badawi, R; El-Kalla, F; Elfert, A; Elkhalawany, W; ElSawaf, MA; Elwan, N; Hawash, N; Soliman, S | 1 |
2 trial(s) available for nitazoxanide and Hepatic Encephalopathy
| Article | Year |
|---|---|
Nitazoxanide versus rifaximin in preventing the recurrence of hepatic encephalopathy: A randomized double-blind controlled trial.
Topics: Child; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Nitro Compounds; Prospective Studies; Quality of Life; Rifamycins; Rifaximin; Thiazoles | 2021 |
A Randomized Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Nitro Compounds; Thiazoles; Treatment Outcome | 2019 |